This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows
by Zacks Equity Research
GE HealthCare unveils Genesis Radiology Workspace, aiming to streamline imaging workflows and boost diagnostic precision.
BSXPositive Net Change IDXXPositive Net Change CORNegative Net Change GEHCPositive Net Change
medical medical-devices
New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies
by Moumi Mondal
HOLX is set to present new real-world data at RSNA 2025, showing how its AI-driven breast imaging tools boost workflow without sacrificing detection.
HOLXNegative Net Change QGENNegative Net Change GEHCPositive Net Change
medical medical-devices
From Hospitals to ASCs: Will Refurbished Xi Systems Broaden ISRG's Reach?
by Indrajit Bandyopadhyay
ISRG leverages refurbished Xi systems to reach cost-sensitive markets and expand access beyond hospitals.
ISRGNegative Net Change STXSNegative Net Change ZBHPositive Net Change
medical medical-devices
Hims & Hers Expands Care Scope as Digital Health Platforms Evolve
by Debanjana Dey
HIMS expands into low testosterone and menopause care, with plans for longevity and global growth in 2026.
MEDPositive Net Change HIMSNegative Net Change TEMNegative Net Change
medical medical-devices
Sinclair (SBGI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SBGINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Boston Scientific's Margins Strengthen in Q3: What's Driving It?
by Moumi Mondal
BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.
ABTPositive Net Change BSXPositive Net Change GEHCPositive Net Change
medical medical-devices
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
by Moumi Mondal
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
WMTPositive Net Change CVSPositive Net Change
medical medical-devices
5 Stocks With Strong Sales Growth to Bet on Amid Volatile Markets
by Swayta Shah
Stocks like TTWO, GMED, ROK, CNQ and VICI stand out with strong sales growth expectations despite market uncertainty.
TTWOPositive Net Change ROKNegative Net Change CNQPositive Net Change GMEDNegative Net Change VICIPositive Net Change
computers consumer-discretionary medical medical-devices oil-energy reit tech-stocks
GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging
by Zacks Equity Research
GEHC's $2.3B Intelerad deal aims to accelerate cloud imaging growth, expand outpatient reach and boost its shift toward high-margin SaaS revenue.
BSXPositive Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCPositive Net Change
medical medical-devices
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PROFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Globus Medical (GMED) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GMEDNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?
by Moumi Mondal
Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.
BSXPositive Net Change EWPositive Net Change
medical medical-devices
ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership
by Indrajit Bandyopadhyay
Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.
MDTNegative Net Change ISRGNegative Net Change
medical medical-devices
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model
by Debanjana Dey
HIMS expands its connected care model with new diagnostics, hormonal health services and at-home testosterone treatments.
GDRXPositive Net Change HIMSNegative Net Change DOCSPositive Net Change
medical medical-devices
Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.
BSXPositive Net Change ISRGNegative Net Change VEEVNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
by Zacks Equity Research
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
BSXPositive Net Change ANGONo Net Change ISRGNegative Net Change MEDPPositive Net Change
medical medical-devices
Qualys (QLYS)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
QLYSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?
by Moumi Mondal
HOLX's GYN Surgical segment posts its strongest fiscal 2025 growth as MyoSure, Fluent and Gynesonics fuel a standout quarter.
JNJPositive Net Change BDXPositive Net Change HOLXNegative Net Change
medical medical-devices
Four PEG-Driven GARP Winners for the Uncertainty of November 2025
by Urmimala Biswas
Four PEG-driven GARP picks emerge as compelling options amid market turmoil, with ALL, SANM, PAHC and ENS highlighted for their strong growth metrics.
ALLNegative Net Change SANMNegative Net Change ENSNegative Net Change PAHCPositive Net Change
finance industrial-products insurance medical medical-devices tech-stocks
CVS Aetna's New Generative AI Assistant Aims to Simplify Health Care
by Moumi Mondal
CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.
CAHPositive Net Change CVSPositive Net Change CNCPositive Net Change
medical medical-devices
RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures
by Zacks Equity Research
Retractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
RVPPositive Net Change
earnings medical medical-devices
Reasons to Add HealthEquity Stock to Your Portfolio for Now
by Zacks Equity Research
HQY rides on strong HSA growth, AI-driven efficiency gains and solid Q2 results, though data security threats remain a key risk.
BSXPositive Net Change ISRGNegative Net Change HQYNegative Net Change MEDPPositive Net Change
medical medical-devices
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal
by Zacks Equity Research
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 diabetes patients by integrating with the G7 15 day sensor.
MASINegative Net Change DXCMPositive Net Change GMEDNegative Net Change MEDPPositive Net Change
medical medical-devices
3 Stocks With Upgraded Broker Ratings to Buy for Solid Returns
by Swayta Shah
Upgraded broker ratings bring the spotlight to PODD, SNDK and OI as potential picks in a selective market, each showing strong earnings growth and momentum.
OIPositive Net Change SNDKPositive Net Change PODDPositive Net Change
computers industrial-products medical medical-devices tech-stocks
Top Stock Reports for Walmart, Intuitive Surgical & Lam Research
by Mark Vickery
Walmart's omnichannel strength, delivery gains and newer ventures like advertising and membership underscore its solid momentum in Zacks' latest review.
APANo Net Change WMTPositive Net Change ISRGNegative Net Change LRCXPositive Net Change KKRNegative Net Change ORAPositive Net Change BVFLNegative Net Change
aerospace finance medical-devices retail semiconductor